Intestinal epithelial and mucus surface components

The intestinal epithelial and mucus surface components represent a complex physiological barrier rather than a single molecular entity (Johansson et al., 2011, PNAS). This target encompasses the mucus layer, primarily composed of MUC2 mucins, the glycocalyx, and the apical surface of enterocytes (Vancamelbeke & Vermeire, 2017, Therapeutic Advances in Gastroenterology). Together, these elements regulate intestinal permeability and protect the underlying tissue from luminal threats such as pathogens, toxins, and digestive enzymes (Turner, 2009, Nature Reviews Immunology). In clinical pharmacology, this target is the recognized site of action for mucosal protectants and certain antidiarrheal agents like bismuth subsalicylate and sucralfate (PubChem, NIH). These drugs bind to the surface components to form a physical shield, sequester toxins, or stimulate endogenous protective factors like prostaglandins (StatPearls, Sucralfate). Dysregulation of these components is a hallmark of gastrointestinal diseases, including inflammatory bowel disease (IBD) and various enteric infections (Vancamelbeke & Vermeire, 2017). The breakdown of the mucus barrier in these conditions allows for pathogen invasion and subsequent immune activation (Johansson et al., 2011). While not a specific protein or receptor, it is a critical therapeutic focus for maintaining gut integrity and treating mucosal injury (Turner, 2009).

Other names

Intestinal mucosal barrierGut barrierIntestinal mucus layerGastrointestinal mucosal surfaceMucosal surface components

Physical coating of the mucosal surface, sequestration of bacterial toxins, and stimulation of protective prostaglandins and bicarbonate secretion (PubChem; StatPearls).